A. Paju et al. / Tetrahedron Letters 47 (2006) 4491–4493
4493
added and the mixture was again stirred at room temper-
ature for an additional 1 h. The CH2Cl2 layer was
removed and the mixture was acidified with 1 M HCl
solution (pH = 1) and extracted with EtOAc. The com-
bined extracts were dried over MgSO4 and the solvent was
evaporated. The residue was dissolved in CH2Cl2 (20 mL)
and concentrated HCl solution (0.2 mL) was added (in the
case of 3d a catalytic amount of pTsOH was used as the
acid) and the mixture was stirred for 2 h at room
temperature. Then, 10 mL of water was added and the
CH2Cl2 layer was separated. The water layer was extracted
with EtOAc and the combined extracts were dried over
MgSO4. After evaporation of the solvents, the residue was
purified by flash chromatography to give the correspond-
ing c-lactone acids 3.
structure from 3-alkyl-1,2-cyclopentane diones. The
method also has preparative utility.
Acknowledgements
Support from the Estonian Science Foundation (Grant
Nos 5628 and 6778), from the Estonian Ministry of
Education and Science (Grant 0142725s06) and from
the Competence Centre for Cancer Research is
acknowledged.
References and notes
´
8. Kocienski, P. J. In Protecting Groups, 3rd ed.; Thieme:
Stuttgart, NY, 2004; pp 404–405.
9. The synthesized lactone acids have the following physical
characteristics: Compounds 3a, 3b, 3e are identical to
those from Ref. 6b; Compound 3c, 2-[(benzyloxy)methyl]-
5-oxotetrahydrofuran-2-carboxylic acid: 1H NMR (500
MHz, CDCl3): d 9.62 (br s, 1H, OH); 7.35 (m, 2H, m);
7.28–7.32 (m, 3H, o,p); 4.62 (s, 2H, Bn CH2); 3.89 and 3.78
(dd, 2H, J = 10.9 Hz, CH2O), 2.59–2.67 (m, 2H, H-4),
2.35–2.46 (m, 2H, H-3). 13C NMR (125 MHz, CDCl3): d
176.14 (C-5), 174.03 (COOH), 136.97 (s), 128.48 (m),
127.98 (p), 127.73 (o), 85.60 (C-2), 73.86 (Bn CH2), 71.85
1. (a) Tamura, O.; Shiro, T.; Ogasawara, M.; Toyao, A.;
Ishibashi, H. J. Org. Chem. 2005, 70, 4569–4577; (b)
Makino, K.; Shintani, K.; Yamatake, T.; Hara, O.;
Hatano, K.; Hamada, Y. Tetrahedron 2002, 58, 9737–
9740; (c) Masaki, H.; Mizozoe, T.; Esumi, T.; Iwabuchi,
Y.; Hatakeyama, S. Tetrahedron Lett. 2000, 41, 4801–
´
4804; (d) Janecki, T.; Błaszcyk, E.; Studzian, K.; Rozalski,
M.; Krajewska, U.; Janecka, A. J. Med. Chem. 2002, 45,
1142–1145.
2. (a) Kang, J.-H.; Siddiqui, M. A.; Sigano, D. M.; Krajew-
ski, K.; Lewin, N. E.; Pu, Y.; Blumberg, P. M.; Lee, J.;
Marquez, V. E. Org. Lett. 2004, 6, 2413–2416; (b) Duan,
D.; Lewin, N. E.; Sigano, D. M.; Blumberg, P. M.;
Marquez, V. E. J. Med. Chem. 2004, 47, 3248–3254; (c)
Lee, J.; Sharma, R.; Wang, S.; Milne, G. W. A.; Lewin, N.
E.; Szallasi, Z.; Blumberg, P. M.; George, C.; Marquez, V.
E. J. Med. Chem. 1996, 39, 36–45.
3. (a) Pitacco, G.; Sessanta o Santi, A.; Valentin, E.
Tetrahedron: Asymmetry 2000, 11, 3263–3267; (b) Cheˆne-
vert, R.; Duguay, D.; Touraille, F.; Caron, D. Tetra-
hedron: Asymmetry 2004, 15, 863–866.
4. (a) Ravid, U.; Silverstein, R. M.; Smith, R. L. Tetrahedron
1978, 34, 1449–1452; (b) Lee, J.; Wang, S.; Milne, G. W.
A.; Sharma, R.; Lewin, N. E.; Blumberg, P. M.; Marquez,
V. E. J. Med. Chem. 1996, 39, 29–35.
5. (a) Dias, L. C.; de Castro, I. B. D.; Steil, L. J.; Augusto, T.
Tetrahedron Lett. 2006, 47, 213–216; (b) Jang, D.-P.;
Chang, J.-W.; Uang, B.-J. Org. Lett. 2001, 7, 983–985; (c)
Donohoe, T. J.; Stevenson, C. A.; Helliwell, M.; Irshad,
R.; Ladduwahetty, T. Tetrahedron: Asymmetry 1999, 10,
1315–1322.
20
(CH2O), 27.91 (C-4), 27.85 (C-3). ½aꢁD ꢀ10.3 (c 3.34,
CHCl3). Compound 3d, 2-[2-(methoxymethoxy)ethyl]-5-
oxotetrahydrofuran-2-carboxylic acid: 1H NMR (500
MHz, CHCl3): d 8.70 (br s, 1H, OH); 4.57 (s, 2H,
OCH2O); 3.68–3.69 (m, 2H, OCH2CH2); 3.34 (s, 3H,
OCH3); 2.52 and 2.36 (m, 2H, H-4); 2.18 and 1.98 (m, 2H,
OCH2CH2); 2.16 and 2.02 (m, 2H, H-3). 13C NMR
(125 MHz, CDCl3): d 178.86 (C-1), 178.47 (C-5), 96.24
(OCH2O), 75.57 (C-2), 63.58 (CH2O), 55.34 (OCH3),
24
37.88 (OCH2CH2), 33.98 (C-3), 28.39 (C-4). ½aꢁD ꢀ30
(c 3.05, CHCl3). Compound 3f, 2-benzyl-5-oxotetra-
hydrofuran-2-carboxylic acid: 1H NMR (500 MHz,
CDCl3 + DCD3OD): d 7.11–7.20 (m, 5H, o,m,p); 3.26
and 3.03 (2d, 2H, J = 14.6 Hz, Bn CH2); 2.37 and 2.13 (m,
2H, H-3), 2.35 and 1.98 (m, 2H, H-4). 13C NMR
(125 MHz, CDCl3 + DCD3OD): d 176.60 (C-5), 172.95
(COOH), 133.87 (s), 130.25 (o), 128.13 (m), 127.01 (p),
86.27 (C-2), 41.81 (Bn CH2), 29.71 (C-3), 27.84 (C-4).
20
½aꢁD ꢀ5.3 (c 1.97, acetone) and +5.4 (c 2.01, acetone). The
enantiomeric purity of 3c, 3f (directly) and 3d (as
the spirodilactone6b) was determined by chiral HPLC
(Diecel Chiralcel ODH).
6. (a) Paju, A.; Kanger, T.; Pehk, T.; Lopp, M. Tetrahedron
Lett. 2000, 41, 6883–6887; (b) Paju, A.; Kanger, T.; Pehk,
10. The NMR and IR spectra are identical to those from Ref.
4b, however, the chemical shifts for the two proton AB
systems of the a-methylene carbons to the ring should be
exchanged on the basis of J-based selective 1H–13C
polarization transfer experiments. Assignment of 13C
NMR shifts follows: 177.55 (C-2), 137.45 (s), 128.40 (m),
127.78 (p), 127.53 (o), 87.68 (C-5), 73.57 (Bn), 72.35
(CH2OCH2), 65.26 (CH2OH), 29.16 (C-5), 25.57 (C-4).
T.; Lindmaa, R.; Muurisepp, A.-M.; Lopp, M. Tetra-
¨ ¨
hedron: Asymmetry 2003, 14, 1565–1573.
7. A typical synthetic procedure: to a solution of Ti(O-i-Pr)4
˚
(0.3 mL, 1 mmol) and 4 A powdered molecular sieves
(100 mg) in CH2Cl2 (6 mL) at ꢀ20 °C under an argon
atmosphere, (+)-DET (0.27 mL, 1.6 mmol) was added and
the mixture was stirred for 15 min. Then, 3-alkyl-2-
hydroxy-2-cyclopenten-1-one (1 mmol) in CH2Cl2
(2.0 mL) was added and the reaction mixture was stirred
for 30 min. Next t-BuOOH (0.4 mL, 2.5 mmol, 6.25 M
solution in decane) was added and the reaction was kept at
ꢀ20 °C for 68 h. Water (6.0 mL) was added and the
mixture was stirred for 1 h at room temperature, then
1.2 mL of 30% NaOH in saturated NaCl solution12 was
21
21
½aꢁD +9.67 (c 2.4, CHCl3) (lit.4b ½aꢁD +7.73 (c 4.4,
CHCl3)).
11. Paju, A.; Kanger, T.; Pehk, T.; Eek, M.; Lopp, M.
Tetrahedron 2004, 60, 9081–9084.
12. Cao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.;
Masamune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987,
109, 5765–5780.